lipo c vs tirzepatide Semaglutide Tirzepatide: Skinny Shots and Weight Loss Options Using Lipo C Injections with

doi: 10.1007/s00787-022-01986-9

10.5665/sleep.1958 88 FryeG

This peptide remains investigational

Curran, M

At a glance Most common cause / nausea and vomiting from GLP-1 GI side effects reducing fluid intake and increasing fluid loss Incidence of nausea (semaglutide 2.4 mg) / approximately 44% of participants in the STEP-1 trial reported nausea Incidence of vomiting (semaglutide 2.4 mg) / approximately 24% in STEP-1, the primary driver of acute fluid loss Incidence of diarrhea (semaglutide 2.4 mg) / approximately 30% in STEP-1, contributing to electrolyte depletion First-line treatment / oral rehydration with electrolytes